Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Fluvoxamine effective in reducing hospitalisation in COVID-19 patients

October 29, 2021 Medical Communications

A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …
News

FDA approve Susvimo for wet age-related macular degeneration

October 29, 2021 Medical Communications

Genentech have announced that Susvimo, previously known as the port delivery system, is the fist wet age-related macular degeneration (AMD) …
News

XBiotech to launch novel therapy for stroke patients in US

October 29, 2021 Medical Communications

Clinical stage biopharmaceutical company, XBiotech, plans to test its new True Human™ antibody therapy for reducing brain injury after stroke, …
News

Companion test for lung cancer approved by FDA

October 22, 2021 Medical Communications

The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …
News

Servier Phase III colorectal cancer trial fails to meet primary endpoint

October 22, 2021 Medical Communications

Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE trial …
News

CDC approves the mixing of COVID shots

October 22, 2021 Medical Communications

The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients …
News

Xtrava Health Receives Emergency Use Authorisation for COVID-19 Ag Test

October 22, 2021 Medical Communications

The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. The easy-to-use, rapid lateral …
News

First Indian anti-cancer drug launches in China

October 15, 2021 Medical Communications

The first Indian anti-cancer drug, Abiraterone Acetate API, has launched in China, by Dr Reddy’s Laboratories. This breakthrough was announced …
News
moderna_norwood_plant

FDA approves emergency booster dose of Moderna’s COVID-19 vaccine

October 15, 2021 Medical Communications

The FDA Advisory Committee has unanimously voted in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine …
News
astrazeneca_sign_sky

EMA begins real-time review of AstraZeneca’s COVID antibody cocktail

October 15, 2021 Medical Communications

The human medicines committee of the EMA has begun the rolling review of AstraZeneca’s antibody-based COVID-19 therapy, the first protective …
News

Abbott Labs recalls two COVID test kits after false positives

October 15, 2021 Medical Communications

A unit of Abbott Laboratories is recalling two COVID-19 lab test kits over concerns they can potentially issue false positives, …
News

UK government COVID response “one of UK’s worst ever public health failures”, inquiry finds

October 12, 2021 Manufacturing and Production, Medical Communications

A 150-page report published on Tuesday by the House of Commons, Science and Technology Committee, and Health and Social Care …
News

Two Indian drugmakers to discontinue MSD’s molnupiravir

October 8, 2021 Medical Communications

AuroBindo Pharma Ltd and MSD Laboratories plan to end their respective trials of MSD’s experimental antiviral drug molnupiravir in moderate …
News
samsung_bioepis

Samsung Biologics partners with Enzolytics Inc for antibody therapies

October 8, 2021 Medical Communications

Leading manufacturing organisation Samsung Biologics, alongside drug development company Enzolytics, have announced the signing of a strategic CDMO partnership agreement. …
News

Talem Therapeutics and Pierre Fabre to form antibody research collaboration

October 8, 2021 Medical Communications

Talem Therapeutics, subsidiary of Immunoprecise Antibodies Ltd (IPA), and the Pierre Fabre pharmaceutical group have announced a multi-target research collaboration, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025